Literature DB >> 23699409

Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress.

Regina M Young1, Daniel Ackerman, Zachary L Quinn, Anthony Mancuso, Michaela Gruber, Liping Liu, Dionysios N Giannoukos, Ekaterina Bobrovnikova-Marjon, J Alan Diehl, Brian Keith, M Celeste Simon.   

Abstract

Solid tumors exhibit heterogeneous microenvironments, often characterized by limiting concentrations of oxygen (O2), glucose, and other nutrients. How oncogenic mutations alter stress response pathways, metabolism, and cell survival in the face of these challenges is incompletely understood. Here we report that constitutive mammalian target of rapamycin complex 1 (mTORC1) activity renders hypoxic cells dependent on exogenous desaturated lipids, as levels of de novo synthesized unsaturated fatty acids are reduced under low O2. Specifically, we demonstrate that hypoxic Tsc2(-/-) (tuberous sclerosis complex 2(-/-)) cells deprived of serum lipids exhibit a magnified unfolded protein response (UPR) but fail to appropriately expand their endoplasmic reticulum (ER), leading to inositol-requiring protein-1 (IRE1)-dependent cell death that can be reversed by the addition of unsaturated lipids. UPR activation and apoptosis were also detected in Tsc2-deficient kidney tumors. Importantly, we observed this phenotype in multiple human cancer cell lines and suggest that cells committed to unregulated growth within ischemic tumor microenvironments are unable to balance lipid and protein synthesis due to a critical limitation in desaturated lipids.

Entities:  

Keywords:  ER stress; UPR; hypoxia; lipid desaturation; mTORC1; tumor microenvironment

Mesh:

Substances:

Year:  2013        PMID: 23699409      PMCID: PMC3672646          DOI: 10.1101/gad.198630.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  45 in total

1.  The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.

Authors:  Y J Kang; M-K Lu; K-L Guan
Journal:  Cell Death Differ       Date:  2010-07-09       Impact factor: 15.828

Review 2.  Links between metabolism and cancer.

Authors:  Chi V Dang
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

3.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

4.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Authors:  Andrew Y Choo; Sang Gyun Kim; Matthew G Vander Heiden; Sarah J Mahoney; Hieu Vu; Sang-Oh Yoon; Lewis C Cantley; John Blenis
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

5.  Chewing the fat on tumor cell metabolism.

Authors:  Jessica L Yecies; Brendan D Manning
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

Review 6.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

7.  Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

Authors:  Daniel K Nomura; Jonathan Z Long; Sherry Niessen; Heather S Hoover; Shu-Wing Ng; Benjamin F Cravatt
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

8.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

9.  Structure of the human mTOR complex I and its implications for rapamycin inhibition.

Authors:  Calvin K Yip; Kazuyoshi Murata; Thomas Walz; David M Sabatini; Seong A Kang
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

10.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

View more
  95 in total

Review 1.  Oncogenes strike a balance between cellular growth and homeostasis.

Authors:  Bo Qiu; M Celeste Simon
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

2.  Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.

Authors:  Arvin M Gouw; Livia S Eberlin; Katherine Margulis; Delaney K Sullivan; Georgia G Toal; Ling Tong; Richard N Zare; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

Review 3.  Lipid droplet functions beyond energy storage.

Authors:  Michael A Welte; Alex P Gould
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-19       Impact factor: 4.698

Review 4.  Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment.

Authors:  Daniel Ackerman; M Celeste Simon
Journal:  Trends Cell Biol       Date:  2014-07-04       Impact factor: 20.808

Review 5.  Endothelial cell metabolism in health and disease: impact of hypoxia.

Authors:  Brian W Wong; Elke Marsch; Lucas Treps; Myriam Baes; Peter Carmeliet
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

Review 6.  Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer.

Authors:  Juan R Cubillos-Ruiz; Sarah E Bettigole; Laurie H Glimcher
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

7.  Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.

Authors:  Arishya Sharma; Allison J Janocha; Brian T Hill; Mitchell R Smith; Serpil C Erzurum; Alexandru Almasan
Journal:  Mol Cancer Res       Date:  2014-07-24       Impact factor: 5.852

8.  The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

Authors:  Arvin M Gouw; Katherine Margulis; Natalie S Liu; Sudha J Raman; Anthony Mancuso; Georgia G Toal; Ling Tong; Adriane Mosley; Annie L Hsieh; Delaney K Sullivan; Zachary E Stine; Brian J Altman; Almut Schulze; Chi V Dang; Richard N Zare; Dean W Felsher
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

9.  Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.

Authors:  Joshua D Ochocki; Sanika Khare; Markus Hess; Daniel Ackerman; Bo Qiu; Jennie I Daisak; Andrew J Worth; Nan Lin; Pearl Lee; Hong Xie; Bo Li; Bradley Wubbenhorst; Tobi G Maguire; Katherine L Nathanson; James C Alwine; Ian A Blair; Itzhak Nissim; Brian Keith; M Celeste Simon
Journal:  Cell Metab       Date:  2018-05-10       Impact factor: 27.287

Review 10.  Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

Authors:  David A Foster; Darin Salloum; Deepak Menon; Maria A Frias
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.